Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway
Cited by 8
Related Papers
HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
|Journal for ImmunoTherapy of Cancer|2020|95
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
|Cancer Biology and Medicine|2021|52
Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2/9 via NF-κB signaling pathway
|International Journal of Oncology|2016|45
B7 score and T cell infiltration stratify immune status in prostate cancer
|Journal for ImmunoTherapy of Cancer|2021|38